fashion -WSS

fashion

author：entertainment 2025-09-28 12:08:51 - browse：7

Mouse embryo in bottle. -- coverage from STAT — A mouse embryo model created entirely from stem cells. Scientists have since used similar systems to build models of human embryos. Jacob Hanna —Weizmann Institute

Earlier this month, a British journalist broke the news that researchers had taken a major step toward growing stem cells into structures that resemble human embryos.

Details about the experiments, and any sort of outside analysis of their quality or significance, were scarce, since the academic paper summarizing the work was still under peer review. But as the news spread around the globe, other scientists who had more quietly been working in the same area quickly posted preprints of their own progress.

Almost overnight, it seemed, the world was awash in different ways to coax stem cells into something that looked like the earliest days of a human life. The pushback was immediate, prompting accusations of overblown claims as well as outcry about ethical considerations and legal guardrails lagging behind the pace of scientific progress. Meanwhile, former Trump adviser Steve Bannon’s podcast, which studies have found to be a top spreader of misinformation, denounced synthetic babies as “the next abomination.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Questions loom on AstraZeneca cancer drug as safety concerns ebb

WSS

Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal

STAT Summit: The economic case for universal basic health care

The struggle to figure out which patients 'deserve' Wegovy

FDA panel to weigh safety of artificial wombs for preterm births

Bankrupt Pear's prescription app helped MassHealth save money, data suggests

Neurocrine congenital adrenal hyperplasia trial succeeds

leisure time

fashion

Wikipedia

Hepatitis C has a cure — but many Americans still lack access to it

What happened to the House vote on health price transparency?

After affirmative action ruling, medical educators look to 'holistic review'

FDA weighs limits of animal data in assessing artificial wombs

ChatGPT in medicine: STAT answers readers' burning questions

Eli Lilly CEO gives to Mike Pence presidential super PAC

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Neurocrine congenital adrenal hyperplasia trial succeeds

Cancer drug shortages should be causing more outrage

CZI to create biohub to build anti

hotspot

Chamber of Commerce, DOJ clash in court over drug prices

The future of Biogen: Pragmatism, ‘moonshots,’ and no Twinkies

Patients, doctors press FTC to beef up hospital merger scrutiny

ADCs take center stage as promising cancer treatments

Roivant's CEO is a star, but biotech's black hole persists

FDA clears Verve to begin U.S. study of gene

leisure time

focus

entertainment

focus